Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Rapport Therapeutics, Inc. RAPP

Set alert

Price alert · RAPP

All alert types
25.05 USD +0.84 +3.47%

At close · Oct 30

25.74 +0.69 +2.75%

After hours · Oct 30, 7:59 PM ET

Bid
25.00 × 2
Ask
25.05 × 2
23.86 Day range 25.43
22.06 52-week range 52.93
YTD
-17.44%
1 year
-6.81%
Open
23.94
Prev close
24.21
Mkt cap
1.48B
Vol
926.56K
Avg vol
696.93K
EPS
-3.03
P/E
0.00
Div yield
0.00%
More statistics
Low
23.86
High
25.43
Forward P/E
-4.92
Beta
1.22
Short ratio
6.70
Inst. own
109.65%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
37.16
200-d avg
35.66
1y target
68.29

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for RAPP has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

19.11 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -10.6×
FY 2022: -71.7×FY 2023: -21.9×FY 2024: -4.7×FY 2025: -10.6×
FY 2022 5y median -16.3× FY 2025
P/S 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 2.9×
FY 2022: 21.5×FY 2023: -14.7×FY 2024: 1.2×FY 2025: 2.9×
FY 2022 5y median 2.1× FY 2025
P/FCF -16.2×
FY 2022: -119×FY 2023: -13.0×FY 2024: -5.5×FY 2025: -16.2×
FY 2022 5y median -14.6× FY 2025
EV/EBITDA -11.2×
FY 2022: -38.4×FY 2023: -8.5×FY 2024: -3.8×FY 2025: -11.2×
FY 2022 5y median -9.8× FY 2025
EV/Sales 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -6.2%
FY 2022: -0.8%FY 2023: -7.7%FY 2024: -18.3%FY 2025: -6.2%
FY 2022 5y median -6.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -23.0%
FY 2022: -54.6%FY 2023: 135.7%FY 2024: -25.6%FY 2025: -23.0%
FY 2022 5y median -24.3% FY 2025
ROIC -25.2%
FY 2022: -34.6%FY 2023: -24.6%FY 2024: -27.1%FY 2025: -25.2%
FY 2022 5y median -26.1% FY 2025
ROA -21.8%
FY 2022: -33.7%FY 2023: -22.4%FY 2024: -24.9%FY 2025: -21.8%
FY 2022 5y median -23.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 FY 2025
Operating Income -50.6%
FY 2022: 0.0%FY 2023: -249.0%FY 2024: -129.6%FY 2025: -50.6%
FY 2022 FY 2025
EPS (diluted) 24.3%
FY 2022: 0.0%FY 2023: -227.6%FY 2024: -297.9%FY 2025: 24.3%
FY 2022 FY 2025
Free Cash Flow -31.0%
FY 2022: 0.0%FY 2023: -717.3%FY 2024: -133.3%FY 2025: -31.0%
FY 2022 FY 2025

Financial Health

Current Ratio 26.2×
FY 2022: 18.8×FY 2023: 17.1×FY 2024: 35.3×FY 2025: 26.2×
FY 2022 5y median 22.5× FY 2025
Quick Ratio 26.2×
FY 2022: 18.8×FY 2023: 17.1×FY 2024: 35.3×FY 2025: 26.2×
FY 2022 5y median 22.5× FY 2025
Debt / Equity 0.0×
FY 2022: 0.5×FY 2023: -0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2022: 2.0×FY 2023: 1.9×FY 2024: 0.7×FY 2025: 0.3×
FY 2022 5y median 1.3× FY 2025
Interest Coverage 0.0×
FY 2022: -36.4×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31